KYOWA Pharmaceutical Industry Co. Ltd., a Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals, for the manufacture of a generic product for filing in Japan. KYOWA will be the first Japanese client for Bora’s Zhunan manufacturing site, which is USFDA, MHRA, and TFDA approved.   The project will leverage manufacturing strengths in Taiwan and increase the visibility of Taiwan’s pharmaceutical capabilities. It also...